Concepedia

Tareq Al Baghdadi

TA

Statistics

Publications

25

Citations

3K

H-Index

19

Active since

2011

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Michigan Cancer Research Consortium

Memorial Sloan Kettering Cancer Center

IHA Hematology Oncology Consultants

Tareq Al Baghdadi is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, medicine, and chemotherapy.

Publications per year

2011–2025

25

Publications

25

Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer

Ramez N. Eskander, Michael W. Sill, Lindsey Beffa et al. · New England Journal of Medicine · 2023 · 701 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Preoperative Treatment of Locally Advanced Rectal Cancer

Deborah Schrag, Qian Shi, Martin R. Weiser et al. · New England Journal of Medicine · 2023 · 448 citations · Full text

Medicine, Oncology, Surgery +17

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

Sandip Pravin Patel, Megan Othus, Young Kwang Chae et al. · Clinical Cancer Research · 2020 · 326 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A

Karen L. Reckamp, Mary W. Redman, Konstantin H. Dragnev et al. · Journal of Clinical Oncology · 2022 · 240 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

1–5 of 25